Ocumetics Technology Corp. (OTC: OTC) has announced the appointment of Michael L. Edwards to its Board of Directors. This strategic move is intended to strengthen the company’s capabilities and enhance its position within the ophthalmic technology industry.
Edwards brings a wealth of experience to Ocumetics, specifically in accounting, taxation, corporate governance, and fundraising. The company anticipates that his expertise will bolster its growth phase.
Ocumetics Technology Corp. is a Canadian research and development company focused on developing advanced vision correction solutions. The company’s mission is to improve patients’ quality of life through innovation in the field of ophthalmology, including intraocular lenses and other vision-enhancing technologies.
Disclaimer: The financial data included is for informational purposes only and not an indication of future performance.